The global market for Genetic Disease Testing was valued at US$ 1026 million in the year 2024 and is projected to reach a revised size of US$ 2054 million by 2031, growing at a CAGR of 11.5% during the forecast period.

Genetic Disease Testing Market

Genetic disease testing, also known as genetic testing, involves analyzing chromosomes, genes, or proteins to identify changes that may lead to genetic disorders. This testing can confirm or rule out suspected genetic conditions or assess the risk of developing or passing on genetic disorders.

Market Development Overview:

In recent years, the genetic disease testing market has seen substantial growth due to advances in genomics, increased awareness of genetic diseases, and growing demand for personalized medicine. The global genetic disease testing market was valued at billions of dollars in 2023 and is expected to expand at a significant compound annual growth rate (CAGR) in the coming years. Factors driving this growth include technological advances in next-generation sequencing (NGS), declining costs of genetic testing, and expanding applications in oncology, rare disease diagnosis, and reproductive health. Governments and healthcare organizations around the world are actively promoting genetic screening programs, further driving market expansion. Direct-to-consumer (DTC) genetic testing is also becoming increasingly popular, with companies offering home testing kits for health risk assessment and ancestry tracing. The market is expected to maintain steady growth as regulators create clearer guidelines for genetic testing services.

Market Development Opportunities:

Next-generation sequencing (NGS) and CRISPR gene editing technologies are revolutionizing genetic testing, enabling faster, more accurate, and more cost-effective diagnoses. The reduction in the cost of whole genome sequencing makes genetic testing more accessible to a wider range of people. As healthcare shifts toward personalized treatment plans, genetic testing is becoming an important tool to tailor treatments to patients’ genetic profiles. Precision oncology in particular benefits from genetic insights that enable targeted cancer treatments. Many rare genetic diseases remain undiagnosed due to the complexity of traditional diagnostic methods. Advances in genetic testing are improving early detection and management of these diseases, creating new market opportunities. With consumers’ growing interest in health and ancestry, demand for direct-to-consumer genetic testing companies has surged. Companies are also developing AI-driven analytics to provide more personalized insights from genetic data.

Market Risks and Challenges:

Genetic testing raises ethical questions about data privacy, consent, and potential misuse of genetic information. Governments are implementing stricter regulations, which could impact market growth if compliance costs increase. As genetic testing companies collect large amounts of sensitive personal data, the risk of data breaches and misuse continues to increase. Ensuring secure storage and ethical use of genetic data is a key concern for industry stakeholders. Despite declining sequencing costs, genetic testing remains expensive in many regions, limiting accessibility to low-income populations. Insurance coverage for genetic testing also varies, impacting adoption rates. Without appropriate genetic counseling, consumers and patients may misinterpret test results, leading to unnecessary anxiety or inappropriate medical decisions. Expanding access to genetic counseling services is critical to mitigating this risk.

This report aims to provide a comprehensive presentation of the global market for Genetic Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Disease Testing.

The Genetic Disease Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genetic Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Genetic Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Genetic Disease Testing Market Report

Report Metric	Details
Report Name	Genetic Disease Testing Market
Accounted market size in year	US$ 1026 million
Forecasted market size in 2031	US$ 2054 million
CAGR	11.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Direct Genetic Testing Indirect Genetic Testing
Segment by Application	Carrier Testing Prenatal Testing Newborn Screening Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Invitae, Ambry Genetics, Exact Sciences, Qiagen, Tempus, 23andme, Veritas Genetics, Myriad Genetics, LabCorp, Blueprint Genetics, Illumina, CENTOGENE, GeneDx, Fulgent Genetics, BGI Genomics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genetic Disease Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Genetic Disease Testing Market growing?

Ans: The Genetic Disease Testing Market witnessing a CAGR of 11.5% during the forecast period 2025-2031.

What is the Genetic Disease Testing Market size in 2031?

Ans: The Genetic Disease Testing Market size in 2031 will be US$ 2054 million.

Who are the main players in the Genetic Disease Testing Market report?

Ans: The main players in the Genetic Disease Testing Market are Invitae, Ambry Genetics, Exact Sciences, Qiagen, Tempus, 23andme, Veritas Genetics, Myriad Genetics, LabCorp, Blueprint Genetics, Illumina, CENTOGENE, GeneDx, Fulgent Genetics, BGI Genomics

What are the Application segmentation covered in the Genetic Disease Testing Market report?

Ans: The Applications covered in the Genetic Disease Testing Market report are Carrier Testing, Prenatal Testing, Newborn Screening, Others

What are the Type segmentation covered in the Genetic Disease Testing Market report?

Ans: The Types covered in the Genetic Disease Testing Market report are Direct Genetic Testing, Indirect Genetic Testing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Genetic Disease Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Direct Genetic Testing

1.2.3 Indirect Genetic Testing

1.3 Market by Application

1.3.1 Global Genetic Disease Testing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Carrier Testing

1.3.3 Prenatal Testing

1.3.4 Newborn Screening

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Genetic Disease Testing Market Perspective (2020-2031)

2.2 Global Genetic Disease Testing Growth Trends by Region

2.2.1 Global Genetic Disease Testing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Genetic Disease Testing Historic Market Size by Region (2020-2025)

2.2.3 Genetic Disease Testing Forecasted Market Size by Region (2026-2031)

2.3 Genetic Disease Testing Market Dynamics

2.3.1 Genetic Disease Testing Industry Trends

2.3.2 Genetic Disease Testing Market Drivers

2.3.3 Genetic Disease Testing Market Challenges

2.3.4 Genetic Disease Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Genetic Disease Testing Players by Revenue

3.1.1 Global Top Genetic Disease Testing Players by Revenue (2020-2025)

3.1.2 Global Genetic Disease Testing Revenue Market Share by Players (2020-2025)

3.2 Global Top Genetic Disease Testing Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Genetic Disease Testing Revenue

3.4 Global Genetic Disease Testing Market Concentration Ratio

3.4.1 Global Genetic Disease Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Genetic Disease Testing Revenue in 2024

3.5 Global Key Players of Genetic Disease Testing Head office and Area Served

3.6 Global Key Players of Genetic Disease Testing, Product and Application

3.7 Global Key Players of Genetic Disease Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Genetic Disease Testing Breakdown Data by Type

4.1 Global Genetic Disease Testing Historic Market Size by Type (2020-2025)

4.2 Global Genetic Disease Testing Forecasted Market Size by Type (2026-2031)

5 Genetic Disease Testing Breakdown Data by Application

5.1 Global Genetic Disease Testing Historic Market Size by Application (2020-2025)

5.2 Global Genetic Disease Testing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Genetic Disease Testing Market Size (2020-2031)

6.2 North America Genetic Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Genetic Disease Testing Market Size by Country (2020-2025)

6.4 North America Genetic Disease Testing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Genetic Disease Testing Market Size (2020-2031)

7.2 Europe Genetic Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Genetic Disease Testing Market Size by Country (2020-2025)

7.4 Europe Genetic Disease Testing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Genetic Disease Testing Market Size (2020-2031)

8.2 Asia-Pacific Genetic Disease Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Genetic Disease Testing Market Size by Region (2020-2025)

8.4 Asia-Pacific Genetic Disease Testing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Genetic Disease Testing Market Size (2020-2031)

9.2 Latin America Genetic Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Genetic Disease Testing Market Size by Country (2020-2025)

9.4 Latin America Genetic Disease Testing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Genetic Disease Testing Market Size (2020-2031)

10.2 Middle East & Africa Genetic Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Genetic Disease Testing Market Size by Country (2020-2025)

10.4 Middle East & Africa Genetic Disease Testing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Invitae

11.1.1 Invitae Company Details

11.1.2 Invitae Business Overview

11.1.3 Invitae Genetic Disease Testing Introduction

11.1.4 Invitae Revenue in Genetic Disease Testing Business (2020-2025)

11.1.5 Invitae Recent Development

11.2 Ambry Genetics

11.2.1 Ambry Genetics Company Details

11.2.2 Ambry Genetics Business Overview

11.2.3 Ambry Genetics Genetic Disease Testing Introduction

11.2.4 Ambry Genetics Revenue in Genetic Disease Testing Business (2020-2025)

11.2.5 Ambry Genetics Recent Development

11.3 Exact Sciences

11.3.1 Exact Sciences Company Details

11.3.2 Exact Sciences Business Overview

11.3.3 Exact Sciences Genetic Disease Testing Introduction

11.3.4 Exact Sciences Revenue in Genetic Disease Testing Business (2020-2025)

11.3.5 Exact Sciences Recent Development

11.4 Qiagen

11.4.1 Qiagen Company Details

11.4.2 Qiagen Business Overview

11.4.3 Qiagen Genetic Disease Testing Introduction

11.4.4 Qiagen Revenue in Genetic Disease Testing Business (2020-2025)

11.4.5 Qiagen Recent Development

11.5 Tempus

11.5.1 Tempus Company Details

11.5.2 Tempus Business Overview

11.5.3 Tempus Genetic Disease Testing Introduction

11.5.4 Tempus Revenue in Genetic Disease Testing Business (2020-2025)

11.5.5 Tempus Recent Development

11.6 23andme

11.6.1 23andme Company Details

11.6.2 23andme Business Overview

11.6.3 23andme Genetic Disease Testing Introduction

11.6.4 23andme Revenue in Genetic Disease Testing Business (2020-2025)

11.6.5 23andme Recent Development

11.7 Veritas Genetics

11.7.1 Veritas Genetics Company Details

11.7.2 Veritas Genetics Business Overview

11.7.3 Veritas Genetics Genetic Disease Testing Introduction

11.7.4 Veritas Genetics Revenue in Genetic Disease Testing Business (2020-2025)

11.7.5 Veritas Genetics Recent Development

11.8 Myriad Genetics

11.8.1 Myriad Genetics Company Details

11.8.2 Myriad Genetics Business Overview

11.8.3 Myriad Genetics Genetic Disease Testing Introduction

11.8.4 Myriad Genetics Revenue in Genetic Disease Testing Business (2020-2025)

11.8.5 Myriad Genetics Recent Development

11.9 LabCorp

11.9.1 LabCorp Company Details

11.9.2 LabCorp Business Overview

11.9.3 LabCorp Genetic Disease Testing Introduction

11.9.4 LabCorp Revenue in Genetic Disease Testing Business (2020-2025)

11.9.5 LabCorp Recent Development

11.10 Blueprint Genetics

11.10.1 Blueprint Genetics Company Details

11.10.2 Blueprint Genetics Business Overview

11.10.3 Blueprint Genetics Genetic Disease Testing Introduction

11.10.4 Blueprint Genetics Revenue in Genetic Disease Testing Business (2020-2025)

11.10.5 Blueprint Genetics Recent Development

11.11 Illumina

11.11.1 Illumina Company Details

11.11.2 Illumina Business Overview

11.11.3 Illumina Genetic Disease Testing Introduction

11.11.4 Illumina Revenue in Genetic Disease Testing Business (2020-2025)

11.11.5 Illumina Recent Development

11.12 CENTOGENE

11.12.1 CENTOGENE Company Details

11.12.2 CENTOGENE Business Overview

11.12.3 CENTOGENE Genetic Disease Testing Introduction

11.12.4 CENTOGENE Revenue in Genetic Disease Testing Business (2020-2025)

11.12.5 CENTOGENE Recent Development

11.13 GeneDx

11.13.1 GeneDx Company Details

11.13.2 GeneDx Business Overview

11.13.3 GeneDx Genetic Disease Testing Introduction

11.13.4 GeneDx Revenue in Genetic Disease Testing Business (2020-2025)

11.13.5 GeneDx Recent Development

11.14 Fulgent Genetics

11.14.1 Fulgent Genetics Company Details

11.14.2 Fulgent Genetics Business Overview

11.14.3 Fulgent Genetics Genetic Disease Testing Introduction

11.14.4 Fulgent Genetics Revenue in Genetic Disease Testing Business (2020-2025)

11.14.5 Fulgent Genetics Recent Development

11.15 BGI Genomics

11.15.1 BGI Genomics Company Details

11.15.2 BGI Genomics Business Overview

11.15.3 BGI Genomics Genetic Disease Testing Introduction

11.15.4 BGI Genomics Revenue in Genetic Disease Testing Business (2020-2025)

11.15.5 BGI Genomics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Genetic Disease Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Direct Genetic Testing

Table 3. Key Players of Indirect Genetic Testing

Table 4. Global Genetic Disease Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Genetic Disease Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Genetic Disease Testing Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Genetic Disease Testing Market Share by Region (2020-2025)

Table 8. Global Genetic Disease Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Genetic Disease Testing Market Share by Region (2026-2031)

Table 10. Genetic Disease Testing Market Trends

Table 11. Genetic Disease Testing Market Drivers

Table 12. Genetic Disease Testing Market Challenges

Table 13. Genetic Disease Testing Market Restraints

Table 14. Global Genetic Disease Testing Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Genetic Disease Testing Market Share by Players (2020-2025)

Table 16. Global Top Genetic Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Disease Testing as of 2024)

Table 17. Ranking of Global Top Genetic Disease Testing Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Genetic Disease Testing Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Genetic Disease Testing, Headquarters and Area Served

Table 20. Global Key Players of Genetic Disease Testing, Product and Application

Table 21. Global Key Players of Genetic Disease Testing, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Genetic Disease Testing Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Genetic Disease Testing Revenue Market Share by Type (2020-2025)

Table 25. Global Genetic Disease Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Genetic Disease Testing Revenue Market Share by Type (2026-2031)

Table 27. Global Genetic Disease Testing Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Genetic Disease Testing Revenue Market Share by Application (2020-2025)

Table 29. Global Genetic Disease Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Genetic Disease Testing Revenue Market Share by Application (2026-2031)

Table 31. North America Genetic Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Genetic Disease Testing Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Genetic Disease Testing Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Genetic Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Genetic Disease Testing Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Genetic Disease Testing Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Genetic Disease Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Genetic Disease Testing Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Genetic Disease Testing Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Genetic Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Genetic Disease Testing Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Genetic Disease Testing Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Genetic Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Genetic Disease Testing Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Genetic Disease Testing Market Size by Country (2026-2031) & (US$ Million)

Table 46. Invitae Company Details

Table 47. Invitae Business Overview

Table 48. Invitae Genetic Disease Testing Product

Table 49. Invitae Revenue in Genetic Disease Testing Business (2020-2025) & (US$ Million)

Table 50. Invitae Recent Development

Table 51. Ambry Genetics Company Details

Table 52. Ambry Genetics Business Overview

Table 53. Ambry Genetics Genetic Disease Testing Product

Table 54. Ambry Genetics Revenue in Genetic Disease Testing Business (2020-2025) & (US$ Million)

Table 55. Ambry Genetics Recent Development

Table 56. Exact Sciences Company Details

Table 57. Exact Sciences Business Overview

Table 58. Exact Sciences Genetic Disease Testing Product

Table 59. Exact Sciences Revenue in Genetic Disease Testing Business (2020-2025) & (US$ Million)

Table 60. Exact Sciences Recent Development

Table 61. Qiagen Company Details

Table 62. Qiagen Business Overview

Table 63. Qiagen Genetic Disease Testing Product

Table 64. Qiagen Revenue in Genetic Disease Testing Business (2020-2025) & (US$ Million)

Table 65. Qiagen Recent Development

Table 66. Tempus Company Details

Table 67. Tempus Business Overview

Table 68. Tempus Genetic Disease Testing Product

Table 69. Tempus Revenue in Genetic Disease Testing Business (2020-2025) & (US$ Million)

Table 70. Tempus Recent Development

Table 71. 23andme Company Details

Table 72. 23andme Business Overview

Table 73. 23andme Genetic Disease Testing Product

Table 74. 23andme Revenue in Genetic Disease Testing Business (2020-2025) & (US$ Million)

Table 75. 23andme Recent Development

Table 76. Veritas Genetics Company Details

Table 77. Veritas Genetics Business Overview

Table 78. Veritas Genetics Genetic Disease Testing Product

Table 79. Veritas Genetics Revenue in Genetic Disease Testing Business (2020-2025) & (US$ Million)

Table 80. Veritas Genetics Recent Development

Table 81. Myriad Genetics Company Details

Table 82. Myriad Genetics Business Overview

Table 83. Myriad Genetics Genetic Disease Testing Product

Table 84. Myriad Genetics Revenue in Genetic Disease Testing Business (2020-2025) & (US$ Million)

Table 85. Myriad Genetics Recent Development

Table 86. LabCorp Company Details

Table 87. LabCorp Business Overview

Table 88. LabCorp Genetic Disease Testing Product

Table 89. LabCorp Revenue in Genetic Disease Testing Business (2020-2025) & (US$ Million)

Table 90. LabCorp Recent Development

Table 91. Blueprint Genetics Company Details

Table 92. Blueprint Genetics Business Overview

Table 93. Blueprint Genetics Genetic Disease Testing Product

Table 94. Blueprint Genetics Revenue in Genetic Disease Testing Business (2020-2025) & (US$ Million)

Table 95. Blueprint Genetics Recent Development

Table 96. Illumina Company Details

Table 97. Illumina Business Overview

Table 98. Illumina Genetic Disease Testing Product

Table 99. Illumina Revenue in Genetic Disease Testing Business (2020-2025) & (US$ Million)

Table 100. Illumina Recent Development

Table 101. CENTOGENE Company Details

Table 102. CENTOGENE Business Overview

Table 103. CENTOGENE Genetic Disease Testing Product

Table 104. CENTOGENE Revenue in Genetic Disease Testing Business (2020-2025) & (US$ Million)

Table 105. CENTOGENE Recent Development

Table 106. GeneDx Company Details

Table 107. GeneDx Business Overview

Table 108. GeneDx Genetic Disease Testing Product

Table 109. GeneDx Revenue in Genetic Disease Testing Business (2020-2025) & (US$ Million)

Table 110. GeneDx Recent Development

Table 111. Fulgent Genetics Company Details

Table 112. Fulgent Genetics Business Overview

Table 113. Fulgent Genetics Genetic Disease Testing Product

Table 114. Fulgent Genetics Revenue in Genetic Disease Testing Business (2020-2025) & (US$ Million)

Table 115. Fulgent Genetics Recent Development

Table 116. BGI Genomics Company Details

Table 117. BGI Genomics Business Overview

Table 118. BGI Genomics Genetic Disease Testing Product

Table 119. BGI Genomics Revenue in Genetic Disease Testing Business (2020-2025) & (US$ Million)

Table 120. BGI Genomics Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Genetic Disease Testing Picture

Figure 2. Global Genetic Disease Testing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Genetic Disease Testing Market Share by Type: 2024 VS 2031

Figure 4. Direct Genetic Testing Features

Figure 5. Indirect Genetic Testing Features

Figure 6. Global Genetic Disease Testing Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Genetic Disease Testing Market Share by Application: 2024 VS 2031

Figure 8. Carrier Testing Case Studies

Figure 9. Prenatal Testing Case Studies

Figure 10. Newborn Screening Case Studies

Figure 11. Others Case Studies

Figure 12. Genetic Disease Testing Report Years Considered

Figure 13. Global Genetic Disease Testing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Genetic Disease Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Genetic Disease Testing Market Share by Region: 2024 VS 2031

Figure 16. Global Genetic Disease Testing Market Share by Players in 2024

Figure 17. Global Genetic Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Genetic Disease Testing Revenue in 2024

Figure 19. North America Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Genetic Disease Testing Market Share by Country (2020-2031)

Figure 21. United States Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Genetic Disease Testing Market Share by Country (2020-2031)

Figure 25. Germany Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Genetic Disease Testing Market Share by Region (2020-2031)

Figure 33. China Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Genetic Disease Testing Market Share by Country (2020-2031)

Figure 41. Mexico Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Genetic Disease Testing Market Share by Country (2020-2031)

Figure 45. Turkey Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Genetic Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Invitae Revenue Growth Rate in Genetic Disease Testing Business (2020-2025)

Figure 49. Ambry Genetics Revenue Growth Rate in Genetic Disease Testing Business (2020-2025)

Figure 50. Exact Sciences Revenue Growth Rate in Genetic Disease Testing Business (2020-2025)

Figure 51. Qiagen Revenue Growth Rate in Genetic Disease Testing Business (2020-2025)

Figure 52. Tempus Revenue Growth Rate in Genetic Disease Testing Business (2020-2025)

Figure 53. 23andme Revenue Growth Rate in Genetic Disease Testing Business (2020-2025)

Figure 54. Veritas Genetics Revenue Growth Rate in Genetic Disease Testing Business (2020-2025)

Figure 55. Myriad Genetics Revenue Growth Rate in Genetic Disease Testing Business (2020-2025)

Figure 56. LabCorp Revenue Growth Rate in Genetic Disease Testing Business (2020-2025)

Figure 57. Blueprint Genetics Revenue Growth Rate in Genetic Disease Testing Business (2020-2025)

Figure 58. Illumina Revenue Growth Rate in Genetic Disease Testing Business (2020-2025)

Figure 59. CENTOGENE Revenue Growth Rate in Genetic Disease Testing Business (2020-2025)

Figure 60. GeneDx Revenue Growth Rate in Genetic Disease Testing Business (2020-2025)

Figure 61. Fulgent Genetics Revenue Growth Rate in Genetic Disease Testing Business (2020-2025)

Figure 62. BGI Genomics Revenue Growth Rate in Genetic Disease Testing Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Alzheimer Disease Genetic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Genetic Testing for Cancer Risk Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global DNA Genomic Testing Market Research Report 2024

Horse DNA Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Customized Genetic Testing Market Research Report 2025

Global Disease Risk and Health Genetic Test Market Insights Forecast to 2030

Global DNA Genetic Testing Kit Market Research Report 2024

Alzheimer Disease DNA Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Carrier Screening Tests Market Research Report 2024

Global Prenatal Genetic Screening Test Market Research Report 2024

Global Hereditary Testing Market Insights Forecast to 2030

Global Animal Genetic Testing Service Market Research Report 2024

Global Metabolic Genetic Testing Market Research Report 2025

Global Hereditary Genetic Testing Market Research Report 2024

Global Genetic Counseling and Testing Service Market Research Report 2024

Global Direct to consumer Disease Risk and Health Genetic Test Market Insights Forecast to 2030

Global Newborn and Prenatal Genetic Testing Market Insights Forecast to 2030

Global Disease Risk and Health DNA Test Market Insights Forecast to 2030

Pediatric Genetic Testing Market

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions